TRIMURTHILTD logo

Novelix Pharmaceuticals Ltd

TRIMURTHILTD·NSE·
0.00 +0.00 (+0.00%)
Market Cap234.89 Cr
PE Ratio63.40
Volume
Day High - Low
52W High-Low92.00 - 38.00
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
2.0/10
Poor
Fair Value
Sign in to see
ROE
8.00%
Weak
P/E
63.40x
Expensive
Debt / Equity
0.09
Low
Industry
Retail
Pharmacy Retail
Overall View
Mixed

Price performance

52W38.00
92.00
DocStoX take

Supported by growth (9.0), but held back by valuation (0.0). Growth looks strong at 9.0, but that is offset by valuation at 0.0 and quality at 0.3. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Medium confidence
2.0
/10
Poor
Quality
Weak
ROE 8.0%
Valuation
Expensive
P/E 63.4×
Growth
Strong
Revenue +55.9% 5Y CAGR
Risk
Elevated
D/E 0.09
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹235 Cr
52W High / Low
₹92 / ₹38
Dividend Yield
0.00%
Promoter Holding
54.29%
EPS (TTM)
₹0.08
Book Value
₹23.08

Key highlights

  • Revenue compounding 56% a year
  • Low leverage — D/E 0.09
  • Loss-making in some of the last 5 years
  • Quality is weak (0.3/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Retail stocks · Pharmacy Retail

Novelix Pharmaceuticals Ltd peers in Retail

Other Retail stocks on the NSE & BSE. See the full Retail sector list.